The approval broadens Vetmedin’s label, which already covers management of mild to severe congestive heart failure in dogs with clinical myxomatous mitral valve disease or dilated cardiomyopathy.
The MarketWatch News Department was not involved in the creation of this content.-- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimob ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback